Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-24

Clinical Trial Update: Study to Examine the Effects of Oral Fenretinide [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral fenretinide for dengue has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenretinide (fenretinide)

Snippet

Sponsor: Island Pharmaceuticals | Conditions: Dengue | Phase 2 | Status: COMPLETED